Alpha-1 adrenergic antagonists use increases the risk of sleep apnea: implications for understanding the role of prazosin in posttraumatic stress syndrome
- PMID: 32022675
- PMCID: PMC7161435
- DOI: 10.5664/jcsm.8296
Alpha-1 adrenergic antagonists use increases the risk of sleep apnea: implications for understanding the role of prazosin in posttraumatic stress syndrome
Abstract
McCall WV. Alpha-1 adrenergic antagonists use increases the risk of sleep apnea: implications for understanding the role of prazosin in posttraumatic stress syndrome. J Clin Sleep Med. 2020;16(4):643.
Comment in
-
Author response.J Clin Sleep Med. 2020 Apr 15;16(4):645-646. doi: 10.5664/jcsm.8298. J Clin Sleep Med. 2020. PMID: 32022676 Free PMC article.
Comment on
-
Alpha-1 Adrenergic-Antagonist Use Increases the Risk of Sleep Apnea: A Nationwide Population-Based Cohort Study.J Clin Sleep Med. 2019 Nov 15;15(11):1571-1579. doi: 10.5664/jcsm.8014. J Clin Sleep Med. 2019. PMID: 31739846 Free PMC article.
References
-
- George K, Kebejian L, Ruth LJ, et al. Meta-analysis of the efficacy and safety of prazosin versus placebo for the treatment of nightmares and sleep disturbances in adults with posttraumatic stress disorder. J Trauma Dissociation. 2016;17(4):494–510. - PubMed
-
- Raskind MA, Peterson K, Williams T, et al. A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afghanistan. Am J Psychiatry. 2013;170(9):1003–1010. - PubMed
-
- Raskind MA, Peskind ER, Chow B, et al. Trial of prazosin for post-traumatic stress disorder in military veterans. N Engl J Med. 2018;378(6):507–517. - PubMed
-
- McCall W, Pillai A, Case D, et al. A pilot, randomized clinical trial of bedtime doses of prazosin versus placebo in suicidal posttraumatic stress disorder patients with nightmares. J Clin Psychopharmacol. 2018;38(6):618–621. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical